我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

阿司匹林对心肌微血管内皮细胞血管新生功能的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第3期
页码:
265-270
栏目:
基础研究
出版日期:
2015-01-11

文章信息/Info

Title:
Effect of aspirin on myocardial microvascular endothelial cells and its angiogenesis functions
作者:
马晓磊; 吕安林; 郭忠尚; 邱翠婷; 姜晓宇; 李 珊; 郭 显
（第四军医大学西京医院心血管内科，陕西 西安 710032）
Author(s):
MA Xiao-lei;  L? An-lin;  GUO Zhong-shang;  QIU Cui-ting;  JIANG Xiao-yu;  LI Shan;  GUO Xian
(Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
阿司匹林; 心肌; 微血管内皮细胞; 血管新生
Keywords:
aspirin;  myocardium;  microvascular endothelial cells;  angiogenesis
分类号:
R541.5
DOI:
-
文献标识码:
A
摘要:
目的:探讨不同剂量阿司匹林对大鼠心肌微血管内皮细胞（CMECs）血管新生功能的影响和可能的机制。方法:消化法分离大鼠CMECs，用不同浓度（1、10、100、1 000和5 000 μmol/L）的阿司匹林处理体外培养的大鼠CMECs后，分别用CCK-8比色法检测细胞增殖、TUNEL法检测细胞凋亡、划痕试验及Transwell小室评价细胞迁移能力、成管实验评价血管新生能力、Western blot法检测蛋白激酶B（AKT）磷酸化水平，ELISA法测定纤维连接蛋白（FN）表达。结果: ①1、10和100 μmol/L的阿司匹林对，CMECs的增殖、凋亡和AKT磷酸化水平无明显影响，1000、5000μmol/L的阿司匹林对组显著抑制CMECs增殖、下调AKT磷酸化水平、诱导细胞凋亡；②10、100 μmol/L的阿司匹林促进CMECs迁移、成管；③FN表达随阿司匹林浓度升高而升高。结论:①低浓度阿司匹林（1~100μmol/L）对CMECs的存活无明显影响，而高浓度的阿司匹林（1 000、5 000 μmol/L）显著抑制CMECs增殖、下调AKT磷酸化水平、细胞凋亡增多。②低浓度阿司匹林（1~100 μmol/L）作用下，阿司匹林促进CMECs迁移、成管能力，可能与阿司匹林作为环氧化酶（COX）抑制剂，减少前列环素（PGI2）生成引起FN表达上调有关。
Abstract:
AIM:To investigate the effects of different doses of aspirin on angiogenic functions of rat myocardial microvascular endothelial cells (CMECs) and the possible mechanism. METHODS: CMECs were isolated from rats with collagenase digestion and cultured with different doses of aspirin (1, 10, 100, 1 000, 5 000 μmol/L) in vitro. The proliferation of CMECs was analyzed by CCK-8 assay. Apoptotic cells of CMECs were detected by TUNEL. Migration of CMECs was assessed by migration assays. The angiogenic activity of CMECs was examined by tube formation experiment. pAKT protein expression was measured by Western blotting analysis, and FN protein expression was measured by ELISA analysis. RESULTS: Aspirin enhanced CMEC proliferation and pAKT protein expression and induced cell apoptosis at concentrations between 1 000 and 5 000 μmol/L. Aspirin promoted CMEC migration and angiogenesis at concentrations between 10 and 100 μmol/L, and FN protein expression increased with the increasing concentrations of aspirin. CONCLUSION: Low concentrations of aspirin (1-100 μmol/L) exert no obvious effect on the survival of CMECs, whereas high concentrations of aspirin (1 000-5 000 μmol/L) inhibit the proliferation of CMECs, reduce AKT phosphorylation levels and increase apoptosis. At low concentrations of aspirin (1-100 μmol/L), CMEC migration and tube formation are promoted possibly because aspirin, as a ring oxidase (COX) inhibitor, reduces the generation of PGI2 and increases FN expression.

参考文献/References

[1]Awtry EH,Loscalzo J.Aspirin[J].Circulation,2000,101(10):1206-1218.
[2]Scianna M,Bell CG,Preziosi L.Areview of mathematical models for the formation of vascular networks[J].J Theor Biol,2013,333:174-209.
[3]Hu Z,Zhang F,Yang Z,et al.Low-dose aspirin promotes endot helial progenitor cell migration and adhesion and prevents senescence[J].Cell Biol Int,2008,32(7):761-768.
[4]Liu Y,Ma Y,Wang R,et al.Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells[J].Antioxid Redox Signal,2011,15(7):1769-1778.
[5]Holmes CE,Jasielec J,Levis JE,et al.Initiation of aspirin therapy modulates angiogenic protein levels in women with breast Cancer receiving tamoxifen therapy[J].Clin Transl Sci,2013,6(5):386-390.
[6]Patrono C,García Rodríguez LA,Landolfi R,et al.Low-dose aspirin for the prevention of atherothrombosis[J].N Engl J Med,2005,353(22):2373-2383.
[7]Warner TD,Nylander S,Whatling C.Anti-platelet therapy:cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy[J].Br J Clin Pharmacol,2011,72(4):619-633.
[8]Kohyama T,Liu X,Kim HJ,et al.Prostacyclin analogs inhibit fibroblast migration[J].Am J Physiol Lung Cell Mol Physiol,2002,283(2):L428-L432.
[9]Kamio K,Liu X,Sugiura H,et al.Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway[J].Am J Respir Cell Mol Biol,2007,37(1):113-120.
[10]Vane J,Corin RE.Prostacyclin:a vascular mediator[J].Eur J Vasc Endovasc Surg,2003,26(6):571-578.
[11]Cipollone F,Cicolini G,Bucci M.Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives[J].Pharmacol Ther,2008,118(2):161-180.

备注/Memo

备注/Memo:
收稿日期：2014-09-17.
通讯作者：吕安林，副主任医师，主要从事干细胞组织工程和冠心病基础与临床研究Email:19392071@qq.com
作者简介：马晓磊，硕士生Email:ma-xiaolei@163.com
更新日期/Last Update: 2015-02-03